Nika Pharmaceuticals Inc.
NIKA · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $708 | $1,026 | $517 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $708 | $1,027 | $517 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | – | 100% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | 100% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | -6,827.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | 7,982.7% |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | – | – | -100% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |